Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

GENE

Genetic Technologies Ltd. ADR

Apr 23 • 09:49AM ET

2.40

Dollar change +0.03
Percentage change 1.27	%

Healthcare • Diagnostics & Research • Australia • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-28.65	Insider Own	-	Shs Outstand	0.15M	Perf Week	-24.29%
Market Cap	0.46M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-10.11%
Income	-8.44M	PEG	-	EPS next Q	-	Inst Own	12.56%	Short Float	-	Perf Quarter	16.50%
Sales	5.64M	P/S	0.08	EPS this Y	-	Inst Trans	-58.10%	Short Ratio	0.38	Perf Half Y	-34.72%
Book/sh	0.85	P/B	2.81	EPS next Y	-	ROA	-102.77%	Short Interest	0.01M	Perf Year	-56.76%
Cash/sh	13.37	P/C	0.18	EPS next 5Y	-	ROE	-156.80%	52W Range	1.80 - 5.90	Perf YTD	0.00%
Dividend Est.	-	P/FCF	-	EPS past 5Y	13.28%	ROI	-252.56%	52W High	-59.32%	Beta	1.21
Dividend TTM	-	Quick Ratio	1.55	Sales past 5Y	1301.35%	Gross Margin	-37.54%	52W Low	33.33%	ATR (14)	0.24
Dividend Ex-Date	-	Current Ratio	1.67	EPS Y/Y TTM	26.17%	Oper. Margin	-114.53%	RSI (14)	39.37	Volatility	15.89% 9.28%
Employees	60	Debt/Eq	0.08	Sales Y/Y TTM	-8.84%	Profit Margin	-149.49%	Recom	1.00	Target Price	6.87
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	95.41%	Payout	-	Rel Volume	0.26	Prev Close	2.37
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-7.17%	Earnings	Feb 23 AMC	Avg Volume	30.22K	Price	2.40
SMA20	-15.52%	SMA50	-5.47%	SMA200	-24.85%	Trades		Volume	753	Change	1.27%

Apr-22-24 03:00PM	Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering (GlobeNewswire)
Apr-18-24 12:17PM	Genetic Technologies Announces $2 Million Registered Direct Offering (GlobeNewswire) -22.78%
Apr-17-24 08:00AM	New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes (GlobeNewswire)
Apr-16-24 08:00AM	GeneType Clinicians' Adoption Growing - Sales up 5-Fold Year on Year (GlobeNewswire)
Apr-12-24 09:00AM	Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
08:00AM	Loading…
Apr-11-24 08:00AM	GTG to pilot GeneType in Breast Screen centers across the U.S. (GlobeNewswire) +8.18%
Apr-08-24 08:00AM	EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch 'Know Your Risk (GlobeNewswire)
Apr-02-24 08:05AM	Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market (GlobeNewswire)
Mar-26-24 08:00AM	GTG Global Collaborations and Innovation Update (GlobeNewswire) +5.86%
Mar-25-24 08:00AM	GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare (GlobeNewswire)
Feb-28-24 08:00AM	GTG to launch U.S. Customer Digital Media Sales Campaign (GlobeNewswire)
Jan-31-24 08:00AM	Launching our most comprehensive test and expanding into new global markets (GlobeNewswire)
Jan-05-24 08:00AM	Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Dec-29-23 09:00AM	Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV (ACCESSWIRE)
Dec-14-23 08:00AM	GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness (GlobeNewswire) +13.80%
08:00AM	Loading…
Dec-12-23 08:00AM	Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change (GlobeNewswire)
Oct-30-23 08:00AM	Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial (GlobeNewswire)
Oct-18-23 08:30AM	GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment (GlobeNewswire) +10.29%
Oct-06-23 09:00AM	Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV (ACCESSWIRE)
Sep-27-23 03:40PM	Genetic Technologies building pathway to profitability (News Direct)
09:00AM	GTG Signs Precision Medicine Pilot with Australia s Largest Private Hospital Network (GlobeNewswire)
Sep-15-23 09:00AM	Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report(R) on Bloomberg TV (ACCESSWIRE)
Sep-12-23 08:00AM	Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release (GlobeNewswire)
Sep-11-23 08:30AM	GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner (GlobeNewswire) +5.05%
Sep-01-23 10:00AM	Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV (GlobeNewswire) +5.64%
09:00AM	Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV (ACCESSWIRE)
Aug-30-23 08:45AM	Annual Results Momentum Building on our Commercial Plans (GlobeNewswire)
Aug-09-23 08:00AM	Genetic Technologies Limited Announces Updated Investor Presentation (GlobeNewswire)
Jul-28-23 08:00AM	Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume (GlobeNewswire)
Jul-21-23 08:00AM	Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
03:00PM	Loading…
May-26-23 03:00PM	Genetic Technologies embraces global vision for genomic-integrated healthcare (News Direct)
May-23-23 08:00AM	GeneType featured on U.S. National TV to raise Breast Cancer Awareness (GlobeNewswire)
Apr-28-23 08:00AM	New Publication Validates geneType for Melanoma Risk Assessment (GlobeNewswire)
Apr-27-23 08:00AM	Quarterly Business Update March 2023 (GlobeNewswire)
Apr-19-23 08:00AM	Publication Validates geneType Prostate Cancer Risk Test (GlobeNewswire)
Mar-27-23 08:00AM	GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation (GlobeNewswire) +6.36%
Mar-13-23 08:00AM	Back-to-back Studies Validate geneType Breast Cancer Risk Test (GlobeNewswire)
Feb-09-23 08:00AM	New Publication Highlights geneTypes Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification (GlobeNewswire) +21.23%
Feb-07-23 10:00AM	Genetic Technologies Announces Closing of $5 Million Registered Direct Offering (GlobeNewswire) -7.91%
Feb-06-23 08:00AM	Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer (GlobeNewswire)
Feb-03-23 08:35AM	Genetic Technologies Announces $5 Million Registered Direct Offering (GlobeNewswire) +80.20%
08:00AM	GENE to Launch Worlds First Comprehensive Risk Test for Breast & Ovarian Cancer (GlobeNewswire)
07:52AM	Why Genetic Technologies Shares Are Skyrocketing During Premarket Session (Benzinga)
Feb-01-23 02:22PM	Genetic Technologies Shares Jump After Strategic Alliance With Qiagen (Benzinga) +13.19%
08:00AM	GTG to form Strategic Alliance with global testing leader QIAGEN (GlobeNewswire)
Jan-30-23 08:00AM	Quarterly Business Update December 2022; Sixth Consecutive Quarter of Growth (GlobeNewswire) -7.26%
Jan-24-23 08:00AM	Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium (GlobeNewswire)
Jan-11-23 08:00AM	Genetic Technologies Provides Business Update (GlobeNewswire)
Dec-06-22 08:00AM	GeneType published in PLOS ONE development of polygenic risk scores for cardiovascular diseases and type 2 diabetes (GlobeNewswire)
Nov-10-22 08:00AM	Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease (GlobeNewswire)
Nov-09-22 08:00AM	Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention (GlobeNewswire)
Oct-25-22 09:14AM	Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details (GlobeNewswire)
Oct-13-22 08:00AM	Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
Sep-29-22 08:00AM	Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer (GlobeNewswire)
Sep-02-22 08:00AM	Genetic Technologies Provides Update on US Operations and Payer Engagement (GlobeNewswire)
Aug-30-22 08:00AM	GENE Momentum building - a year in review (GlobeNewswire)
Jul-28-22 08:00AM	Gene achieves key milestones and growth (GlobeNewswire)
Jul-18-22 08:00AM	GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians (GlobeNewswire)
Jul-14-22 08:00AM	Completion of AffinityDNA Acquisition expanding global direct-to-consumer business (GlobeNewswire) +7.58%
Jul-05-22 08:00AM	EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage (GlobeNewswire) +5.79%
Jul-01-22 08:00AM	GeneType Risk Assessment Test onboarding in 16 clinics (GlobeNewswire)
Jun-16-22 08:00AM	Transformational Pathway to US Payer System; Attributing US$1.4 Billion Health and Economic Benefit from geneType Breast Cancer Risk Assessment Test (GlobeNewswire)
May-16-22 09:00AM	Acquisition of global direct to consumer ecommerce business (GlobeNewswire)
Apr-08-22 08:00AM	Genetic Technologies drives leadership in precision medicine with Multi-Risk Test (GlobeNewswire)
Feb-23-22 08:00AM	US Patent Office Grants Patent for COVID-19 Risk Test (GlobeNewswire)
Feb-22-22 08:00AM	GeneType Multi-Test Receives Regulatory Approval for Commercial Release in USA and Australia (GlobeNewswire)
Jan-19-22 09:00AM	Genetic Technologies Reports Q2 FY22 Cash Flow Results (GlobeNewswire) +5.64%
Dec-21-21 08:00AM	Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GENE, geneType), a global leader in genomics-based tests in health, wellness and serious disease provides the following business update: (GlobeNewswire)
Dec-10-21 07:30AM	GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium (GlobeNewswire)
Dec-09-21 07:30AM	Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO (GlobeNewswire) -5.79%
Oct-25-21 08:30AM	Genetic Technologies Reports Q1 FY22 Results (GlobeNewswire)
Oct-04-21 08:00AM	GENE Delivers Material 12-Fold Increase in Revenue in the Quarter Ended September 2021 (GlobeNewswire)
Sep-30-21 09:00AM	Genetic Technologies Limited Interview to Air on Bloomberg TV (U.S.) on the RedChip Money Report® (GlobeNewswire)
Sep-28-21 08:04AM	GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity (GlobeNewswire)
Sep-09-21 09:00AM	BelHealth Completes Asset Sale of General Genetics Corp. (PR Newswire)
Aug-31-21 09:00AM	Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy (GlobeNewswire)
Aug-16-21 08:00AM	Genetic Technologies Enters Multi-Billion-Dollar Consumer Genomics Market (GlobeNewswire)
Jul-26-21 08:25AM	Genetic Technologies Rapidly Accelerating Commercialization Plans (GlobeNewswire)
Jul-19-21 09:27AM	Genetic Technologies Acquires EasyDNA To Expand Into Wellness Testing (Benzinga)
08:00AM	Genetic Technologies Strengthens Global Leadership in Genomics with Acquisition of EasyDNA (GlobeNewswire)
Jul-09-21 08:00AM	Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities (GlobeNewswire)
Jun-11-21 08:00AM	US Patent Office Grants Foundational Pharmacogenomic Patent (GlobeNewswire) +9.13%
Jun-01-21 08:00AM	Genetic Technologies COVID-19 Risk Test Now Available in US through Partnership with Infinity BiologiX (GlobeNewswire) -6.57%
May-13-21 09:01AM	Genetic Technologies Interview to Air on Bloomberg Television U.S. on the RedChip Money Report® (GlobeNewswire)
Apr-26-21 08:00AM	Genetic Technologies COVID-19 Risk Test Approved for Commercial Release (GlobeNewswire)
Apr-12-21 09:37AM	Company News for Apr 12, 2021 (Zacks) -7.88%
08:15AM	Genetic Technologies appoints Mike Tonroe as CFO (GlobeNewswire)
Apr-09-21 11:15AM	Genetic Technologies Provides Update on COVID-19 Risk Test Launch (GlobeNewswire) +6.53%
Mar-04-21 07:00AM	Genetic Technologies Signs Multi-Year US Distribution Agreement for COVID Risk Test (GlobeNewswire) -8.17%
Feb-26-21 09:20AM	Genetic Technologies Limited Interview to Air on Bloomberg TV in the US on the RedChip Money Report® (GlobeNewswire)
Jan-25-21 04:00PM	Genetic Technologies Announces Closing of $6.56 Million Registered Direct Offering (GlobeNewswire)
Jan-21-21 11:30AM	Genetic Technologies Announces $6.56 Million Registered Direct Offering (GlobeNewswire) +27.44%
07:00AM	Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing (GlobeNewswire)
Dec-02-20 09:00AM	Genetic Technologies Secures US and ANZ Distribution Rights for PREDICTIX (GlobeNewswire)
Dec-01-20 09:50AM	Have Insiders Been Buying Genetic Technologies Limited (ASX:GTG) Shares? (Simply Wall St.)
Nov-23-20 04:30PM	Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report (GlobeNewswire)
Nov-17-20 08:30AM	Genetic Technologies to Hold Investor Webinar and Q&A Session on November 19 (GlobeNewswire)
Oct-01-20 08:00AM	Genetic Technologies Provides Update on COVID-19 Risk Test (GlobeNewswire)
Sep-15-20 08:00AM	Genetic Technologies Provides Update on COVID-19 Disease Severity Test Development (GlobeNewswire)
Sep-11-20 08:33AM	Genetic Technologies Announces US Sales Have Commenced via Online Health Platform (GlobeNewswire) +9.86%

Genetic Technologies Ltd. operates as a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA, AffinityDNA and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment focuses on AffinityDNA branded test sales and expenses.The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GENE

Genetic Technologies Ltd. ADR

Upgrade your FINVIZ experience